Namba Chikara, Adachi Naoto, Liu Keyue, Yorozuya Toshihiro, Arai Tatsuru
Department of Anesthesiology and Resuscitology, Ehime University School of Medicine, Shitsukawa, Shigenobu-cho, Onsen-gun, Ehime, Japan.
Brain Res. 2002 Dec 13;957(2):271-7. doi: 10.1016/s0006-8993(02)03579-5.
The effects of dexamethasone on adenosine 5'-triphosphatase (ATPase) activity and the intracellular Ca(2+) concentration (Ca(2+)) were investigated in acidotic mouse brain. Dexamethasone (3 mg/kg, i.p.) or vehicle was administered 3 h before decapitation ischemia, and the brain concentration of adenosine 5'-triphosphate (ATP) was determined 0.5-2 min after ischemia. The effects of dexamethasone (0.3-3 mg/kg, i.p.) on Na(+),K(+)-activated ATPase (Na(+),K(+)-ATPase) and Ca(2+)-ATPase activities were evaluated at pH 7.4 and 6.8. Changes in Ca(2+) in an acidic medium were determined in hippocampal slices by microfluorometry using rhod-2 acetoxymethyl ester as a Ca(2+) marker, and the effects of dexamethasone (240 microg/l) was evaluated. Decapitation ischemia for 0.5 and 1 min reduced the brain ATP contents to 32% and 16% of the basal level, respectively. Dexamethasone slightly suppressed the extent of the decrease in the ATP level. Although dexamethasone did not affect Na(+),K(+)-ATPase activity at pH 7.4, the activity was suppressed by dexamethasone (3 mg/kg) to 68% at pH 6.8. The activity of Ca(2+)-ATPase was not affected by dexamethasone at either pH 7.4 or pH 6.8. When the pH of the medium of the brain slices was changed from 7.4 to 6.8, almost no increase in Ca(2+) was observed in the control group. The dexamethasone treatment increased Ca(2+) in the CA1 field and dentate gyrus immediately after induction of the acidic medium, the effect being significant after 150 s. Because anaerobic glucose metabolism in the early stage of ischemia enhances intracellular lactic acidosis, the findings may suggest a mechanism for the aggravation of ischemic neuronal damage by glucocorticoids.
在地酸性小鼠脑中研究了地塞米松对腺苷5'-三磷酸酶(ATP酶)活性和细胞内钙离子浓度([Ca(2+)]i)的影响。在地断头缺血前3小时腹腔注射地塞米松(3毫克/千克)或赋形剂,缺血后0.5至2分钟测定脑内腺苷5'-三磷酸(ATP)的浓度。在pH值为7.4和6.8时评估地塞米松(0.3至3毫克/千克,腹腔注射)对钠钾激活的ATP酶(钠钾ATP酶)和钙ATP酶活性的影响。使用罗丹明-2乙酰甲酯作为钙离子标记物,通过微荧光法测定酸性培养基中脑片内[Ca(2+)]i的变化,并评估地塞米松(240微克/升)的作用。断头缺血0.5分钟和1分钟分别将脑ATP含量降至基础水平的32%和16%。地塞米松轻微抑制了ATP水平下降的程度。虽然地塞米松在pH值为7.4时不影响钠钾ATP酶活性,但在pH值为6.8时,地塞米松(3毫克/千克)将该活性抑制至68%。在pH值为7.4或6.8时,地塞米松均不影响钙ATP酶活性。当脑片培养基的pH值从7.4变为6.8时,对照组几乎未观察到[Ca(2+)]i增加。地塞米松处理在酸性培养基诱导后立即增加了CA1区和齿状回的[Ca(2+)]i,150秒后该作用显著。由于缺血早期的无氧葡萄糖代谢会增强细胞内乳酸酸中毒,这些发现可能提示了糖皮质激素加重缺血性神经元损伤的机制。